# IMA (ImageneBio, Inc.) - SEC EDGAR Financial Statements

> ImageneBio, Inc. reported $800K in revenue and a net loss of $43.33M for the fiscal year ended December 31, 2025 (down 77.1% year over year), with a -6259.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/IMA
- Markdown: https://convexityos.com/fundamentals/IMA.md
- SEC CIK: 0001835579
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001835579&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $800K | -77.1% YoY |
| Operating Income | FY 2025 | -$50.08M | -6259.8% margin |
| Net Income | FY 2025 | -$43.33M | -5415.6% net margin |
| Diluted EPS | FY 2025 | -$2.53 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $126.6M | Total debt: $1.31M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $800K | $3.50M | $9.16M | $15.62M | $30.98M | $9.19M |
| Research & Development | $28.52M | $32.11M | $59.65M | $64.32M | $47.11M | $44.85M |
| Total Operating Expenses | $49.25M | $40.50M | $84.58M | $86.52M | $65.12M | $53.71M |
| **Operating Income** | -$48.45M | -$37.00M | -$75.42M | -$70.90M | -$34.14M | -$44.52M |
| **EBITDA** | -$48.05M | -$35.90M | -$74.40M | -$70.15M | -$33.59M | -$44.22M |
| Interest Income | -- | -- | $7.11M | $2.15M | $23K | -- |
| Income Before Tax | -$45.70M | -$36.55M | -$68.33M | -$68.77M | -- | -- |
| Income Tax Expense | -$350K | $13K | -$162K | $0 | $0 | -- |
| **Net Income** | -$45.35M | -$36.57M | -$68.17M | -$68.77M | -$34.12M | -$44.26M |
| Basic EPS | -$192.80 | -$442.00 | -$32.60 | -$38.00 | -$24.40 | -$320.00 |
| **Diluted EPS** | -$192.80 | -$442.00 | -$32.60 | -$38.00 | -$24.40 | -$320.00 |
| Basic Shares Outstanding | 243.5K | 59.7K | 2.1M | 1.8M | 1.4M | 138.3K |
| Diluted Shares Outstanding | -- | 2.4M | 2.1M | 1.8M | 1.4M | 138.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $800K | -- |
| Research & Development | $11.27M | $6.67M | $5.96M | $3.68M | $15.16M | $5.65M | $4.04M | $3.76M |
| Total Operating Expenses | $17.31M | $11.78M | $12.08M | $8.91M | $26.19M | $7.36M | $6.79M | $6.14M |
| **Operating Income** | -$17.31M | -$11.78M | -$12.08M | -$8.91M | -$26.19M | -$7.36M | -$6.00M | -$6.14M |
| **EBITDA** | -$17.31M | -$11.78M | -$12.08M | -$8.51M | -$26.19M | -$7.36M | -$5.99M | -$6.05M |
| Income Before Tax | -$15.60M | -$10.16M | -$10.61M | -$7.18M | -$24.85M | -$7.58M | -$6.08M | -$4.80M |
| Income Tax Expense | $20K | $16K | $10K | -$276K | -$74K | $15K | $28K | $13K |
| **Net Income** | -$15.62M | -$10.18M | -$10.62M | -$6.91M | -$24.78M | -$7.58M | -$6.08M | -$4.81M |
| Basic EPS | -$0.91 | -$0.63 | -$0.95 | -- | -$2.91 | -$4.46 | -$3.80 | -- |
| **Diluted EPS** | -$0.91 | -$0.63 | -$0.95 | -- | -$2.91 | -$4.46 | -$3.80 | -- |
| Basic Shares Outstanding | 17.1M | -- | 11.2M | -- | 8.8M | 2.4M | 1.4M | -- |
| Diluted Shares Outstanding | 17.1M | 16.2M | 11.2M | -- | 8.8M | 2.4M | 2.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $94.53M | $12.12M | $119.9M | $59.92M | $232.2M | $162.5M |
| Short-Term Investments | $40.82M | $0 | $55.57M | $97.03M | -- | -- |
| **Cash & Short-Term Investments** | $135.3M | $12.12M | $175.5M | $156.9M | $232.2M | $162.5M |
| Other Current Assets | -- | -- | $1.15M | $964K | $629K | $1.54M |
| **Total Current Assets** | $140.3M | $12.47M | $178.7M | $160.0M | $236.5M | $166.0M |
| Property, Plant & Equipment, Net | $0 | $8.0K | $2.33M | $3.21M | $2.44M | $1.39M |
| Other Non-Current Assets | $4.88M | $1.02M | -- | -- | -- | $872K |
| **Total Non-Current Assets** | $12.69M | $3.45M | $13.43M | $12.25M | $11.36M | $2.44M |
| **Total Assets** | $153.0M | $15.92M | $192.1M | $172.3M | $247.9M | $168.4M |
| Accounts Payable | $1.44M | $5.29M | $2.07M | $2.09M | $2.38M | $2.12M |
| Short-Term Debt | $0 | $7.50M | -- | -- | -- | -- |
| Deferred Revenue (Current) | $0 | $650K | -- | $9.16M | $17.10M | $20.62M |
| Other Current Liabilities | $164K | $23K | $85K | $119K | $26K | $380K |
| **Total Current Liabilities** | $11.23M | $17.21M | $14.21M | $21.50M | $27.19M | $28.33M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $7.68M | $35.14M |
| Other Non-Current Liabilities | $870K | $0 | $950K | -- | -- | -- |
| **Total Non-Current Liabilities** | $8.60M | $239K | $8.13M | $3.79M | $12.81M | $35.14M |
| **Total Liabilities** | $19.84M | $17.45M | $22.34M | $25.29M | $40.00M | $63.47M |
| **Total Debt (incl. Leases)** | $2.98M | $15.02M | $10.74M | $5.69M | $6.99M | $186K |
| Common Stock | -- | $48K | $48K | $36K | $36K | $3.0K |
| Retained Earnings | -$230.1M | -$179.9M | -$282.4M | -$214.2M | -$145.5M | -$111.3M |
| Accumulated Other Comp. Income | $87K | -$1.79M | -$48K | -$763K | -- | -- |
| **Total Stockholders' Equity** | $133.1M | -$160.6M | -$126.1M | $147.0M | $207.9M | -$101.0M |
| Total Equity | $133.1M | -$160.6M | -$126.1M | $147.0M | $207.9M | -$101.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $84.85M | $94.68M | $76.05M | $94.53M | $103.2M | $58.29M | $36.76M | $12.12M |
| Short-Term Investments | $41.74M | $41.48M | $41.16M | $40.82M | $39.42M | $37.35M | $77.29M | $0 |
| **Cash & Short-Term Investments** | $126.6M | $136.2M | $117.2M | $135.3M | $142.6M | $95.64M | $114.1M | $12.12M |
| **Total Current Assets** | $130.6M | $141.1M | $122.0M | $140.3M | $147.5M | $99.01M | $117.0M | $12.47M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $1.0K | $419K | $506K | $8.0K |
| Other Non-Current Assets | -- | -- | -- | $4.88M | $4.95M | -- | -- | $1.02M |
| **Total Non-Current Assets** | $11.94M | $10.93M | $14.68M | $12.69M | $13.35M | $27.15M | $13.84M | $3.45M |
| **Total Assets** | $142.5M | $152.0M | $136.7M | $153.0M | $160.9M | $126.2M | $130.8M | $15.92M |
| Accounts Payable | $931K | $977K | $568K | $1.44M | $2.08M | $512K | $805K | $5.29M |
| Short-Term Debt | -- | -- | -- | $0 | $0 | -- | -- | $7.50M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $0 | -- | -- | $650K |
| Other Current Liabilities | $268K | $250K | $316K | $164K | -- | $39K | $140K | $23K |
| **Total Current Liabilities** | $8.07M | $6.57M | $6.63M | $11.23M | $11.14M | $7.32M | $8.79M | $17.21M |
| Other Non-Current Liabilities | $848K | $838K | $881K | $870K | $1.11M | $1.09M | $1.08M | $0 |
| **Total Non-Current Liabilities** | $6.33M | $3.40M | $6.72M | $8.60M | $9.90M | $2.94M | $3.79M | $239K |
| **Total Liabilities** | $14.40M | $9.97M | $13.36M | $19.84M | $21.05M | $10.26M | $12.59M | $17.45M |
| **Total Debt (incl. Leases)** | $1.31M | $1.91M | $2.42M | $2.98M | $3.44M | $5.68M | $6.61M | $15.02M |
| Common Stock | -- | -- | -- | -- | -- | $48K | $48K | $48K |
| Retained Earnings | -$266.5M | -$250.8M | -$240.7M | -$230.1M | -$223.1M | -$343.0M | -$340.2M | -$179.9M |
| Accumulated Other Comp. Income | -$170K | -$51K | -$17K | $87K | $94K | $65K | $99K | -$1.79M |
| **Total Stockholders' Equity** | $128.1M | $142.1M | $123.3M | $133.1M | $139.8M | -$180.4M | -$169.6M | -$160.6M |
| Total Equity | $128.1M | $142.1M | $123.3M | $133.1M | $139.8M | -$180.4M | -$169.6M | -$160.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.35M | -$36.57M | -$68.17M | -$68.77M | -$34.12M | -$44.26M |
| Depreciation & Amortization | $400K | $1.10M | $1.02M | $751K | $544K | $300K |
| Stock-Based Compensation | $15.39M | $0 | $7.63M | $7.53M | $5.18M | $1.80M |
| Change in Payables | -$2.82M | -$523K | -$2.87M | -$291K | $361K | $519K |
| **Operating Cash Flow** | -$47.84M | -$21.32M | -$79.74M | -$74.11M | -$60.25M | -$37.83M |
| Capital Expenditure | -- | -- | -$414K | -$1.43M | -$1.76M | -$766K |
| **Free Cash Flow** | -- | -- | -$80.16M | -$75.54M | -$62.01M | -$38.59M |
| Purchases of Investments | -$10.40M | $0 | -$90.05M | -$216.3M | -- | -- |
| **Investing Cash Flow** | -$5.81M | $11.12M | $64.14M | -$99.28M | -$1.76M | $2.92M |
| Common Stock Issued | -- | -- | $37.42M | -- | -- | -- |
| Share Repurchases | -- | -- | -$663K | -- | -- | -- |
| **Financing Cash Flow** | $135.5M | $6.91M | $75.98M | $1.09M | $131.7M | $116.2M |
| **Net Change in Cash** | $82.41M | -$3.20M | $60.38M | -$172.3M | $69.73M | $81.28M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.62M | -$10.18M | -$10.62M | -$6.91M | -$24.78M | -$7.58M | -$6.08M | -$4.81M |
| Depreciation & Amortization | $0 | $0 | $0 | $393K | $2.0K | $2.0K | $2.0K | $89K |
| Stock-Based Compensation | $1.67M | $911K | $876K | $51K | $15.28M | $0 | $57K | $0 |
| Change in Payables | -$192K | $409K | -$871K | -$641K | -$3.14M | -$464K | $1.43M | $1.71M |
| **Operating Cash Flow** | -$9.52M | -$9.07M | -$14.80M | -$7.22M | -$21.50M | -$11.90M | -$7.23M | -$3.48M |
| Purchases of Investments | -$5.67M | -$8.00M | -$10.94M | -$8.91M | -$1.49M | $0 | $0 | $0 |
| **Investing Cash Flow** | -$385K | -$346K | -$440K | -$1.36M | -$4.45M | $0 | $0 | $103K |
| **Financing Cash Flow** | $82K | $28.05M | -$3.24M | $0 | $122.4M | $13.02M | $27K | -- |
| **Net Change in Cash** | -$9.82M | $18.63M | -$18.48M | -$8.63M | $97.14M | $1.10M | -$7.20M | -$5.80M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -6056.4% | -1057.1% | -823.3% | -454.0% | -110.2% | -484.2% |
| **Net Profit Margin** | -5668.6% | -1044.8% | -744.2% | -440.3% | -110.1% | -481.4% |
| Return on Equity (ROE) | -34.1% | -- | -- | -46.8% | -16.4% | -- |
| Return on Assets (ROA) | -29.6% | -229.7% | -35.5% | -39.9% | -13.8% | -26.3% |
| Current Ratio | 12.49x | 0.72x | 12.58x | 7.44x | 8.70x | 5.86x |
| Quick Ratio | 12.05x | 0.70x | 12.35x | 7.30x | 8.54x | 5.74x |
| Debt to Equity | 0.02x | -- | -- | 0.04x | 0.03x | -- |
| **Revenue Growth (YoY)** | -77.1% | -61.8% | -41.3% | -49.6% | +237.0% | -- |
| 5Y Revenue / Share Growth | -95.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -6056.4% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -5668.6% | -- | -- | -- | -- |
| Return on Equity (ROE) | -33.8% | -36.9% | -40.5% | -34.1% | -30.9% | -- | -- | -- |
| Return on Assets (ROA) | -30.4% | -34.5% | -36.5% | -29.6% | -26.9% | -17.2% | -15.5% | -229.7% |
| Current Ratio | 16.17x | 21.47x | 18.39x | 12.49x | 13.24x | 13.52x | 13.31x | 0.72x |
| Quick Ratio | 15.68x | 20.72x | 17.67x | 12.05x | 12.79x | 13.06x | 12.97x | 0.70x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -100.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -265.8% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
